» Articles » PMID: 36454362

PGT-A is Associated with Reduced Cumulative Live Birth Rate in First Reported IVF Stimulation Cycles Age ≤ 40: an Analysis of 133,494 Autologous Cycles Reported to SART CORS

Overview
Publisher Springer
Date 2022 Dec 1
PMID 36454362
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the impact of preimplantation genetic testing for aneuploidy (PGT-A) on cumulative live birth rate (CLBR) in IVF cycles.

Methods: Retrospective cohort study of the SART CORS database, comparing CLBR for patients using autologous oocytes, with or without PGT-A. The first reported autologous ovarian stimulation cycle per patient between January 1, 2014, and December 31, 2015, and all linked embryo transfer cycles between January 1, 2014, and December 31, 2016, were included in the study. Exclusion criteria were donor oocyte cycles, donor embryo cycles, gestational carrier cycles, cycles which included both a fresh embryo transfer (ET) combined with a thawed embryo previously frozen (ET plus FET), or cycles with a fresh ET after PGT-A.

Results: A total of 133,494 autologous IVF cycles were analyzed. Amongst patients who had blastocysts available for either ET or PGT-A, including those without transferrable embryos, decreased CLBR was noted in the PGT-A group at all ages, except ages > 40 (p < 0.01). A subgroup analysis of only those patients who had PGT-A and a subsequent FET, excluding those without transferrable embryos, demonstrated a very high CLBR, ranging from 71.2% at age < 35 to 50.2% at age > 42. Rates of multiple gestations, preterm birth, early pregnancy loss, and low birth weight were all greater in the non-PGT-A group.

Conclusions: PGT-A was associated with decreased CLBR amongst all patients who had blastocysts available for ET or PGT-A, except those aged > 40. The negative association of PGT-A use and CLBR per cycle start was especially pronounced at age < 35.

Citing Articles

Unveiling clinic variation in utilization of ICSI, PGT, and blastocyst transfer: a comprehensive study using the SART database (2014-2020).

Claffey A, Ngo A, McIntire D, Doody K, Doody K J Assist Reprod Genet. 2025; .

PMID: 39910000 DOI: 10.1007/s10815-025-03413-9.


Greater PGT-A utilization in IVF clinics does not improve live birth rates but relates to IVF center ownership: a preliminary report.

Patrizio P, Darmon S, Barad D, Gleicher N J Assist Reprod Genet. 2024; 42(1):81-84.

PMID: 39643780 PMC: 11805722. DOI: 10.1007/s10815-024-03340-1.


From live birth to live birth: a strong correlation between the outcomes of first and second frozen-thawed euploid blastocyst transfers from sibling oocytes.

Turgut N, Boynukalin F, Gultomruk M, Yarkiner Z, Abali R, Bahceci M J Assist Reprod Genet. 2024; 42(1):193-200.

PMID: 39562396 PMC: 11806171. DOI: 10.1007/s10815-024-03329-w.


Acupuncture improves the live birth of patients with repeated implantation failure: a retrospective cohort study.

Junjian S, Henghui X, Huanhuan L, Xiangming T, Yigong F, Wenhui Z J Tradit Chin Med. 2024; 44(4):830-838.

PMID: 39066544 PMC: 11337250. DOI: 10.19852/j.cnki.jtcm.20240515.006.


Basal FSH values are positively associated with aneuploidy incidence in pre-advanced maternal age (AMA) but not in AMA patients.

Jacobs C, Nicolielo M, Alegretti J, Dal Canto M, Mignini Renzini M, De Ponti E J Assist Reprod Genet. 2024; 41(9):2397-2404.

PMID: 38995508 PMC: 11405722. DOI: 10.1007/s10815-024-03190-x.


References
1.
Yeung Q, Zhang Y, Chung J, Lui W, Kwok Y, Gui B . A prospective study of non-invasive preimplantation genetic testing for aneuploidies (NiPGT-A) using next-generation sequencing (NGS) on spent culture media (SCM). J Assist Reprod Genet. 2019; 36(8):1609-1621. PMC: 6707994. DOI: 10.1007/s10815-019-01517-7. View

2.
Franasiak J, Forman E, Hong K, Werner M, Upham K, Treff N . The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2013; 101(3):656-663.e1. DOI: 10.1016/j.fertnstert.2013.11.004. View

3.
Simopoulou M, Sfakianoudis K, Maziotis E, Tsioulou P, Grigoriadis S, Rapani A . PGT-A: who and when? Α systematic review and network meta-analysis of RCTs. J Assist Reprod Genet. 2021; 38(8):1939-1957. PMC: 8417193. DOI: 10.1007/s10815-021-02227-9. View

4.
Esfandiari N, Bunnell M, Casper R . Human embryo mosaicism: did we drop the ball on chromosomal testing?. J Assist Reprod Genet. 2016; 33(11):1439-1444. PMC: 5125153. DOI: 10.1007/s10815-016-0797-y. View

5.
Doyle N, Gainty M, Eubanks A, Doyle J, Hayes H, Tucker M . Donor oocyte recipients do not benefit from preimplantation genetic testing for aneuploidy to improve pregnancy outcomes. Hum Reprod. 2020; 35(11):2548-2555. PMC: 7821705. DOI: 10.1093/humrep/deaa219. View